Fortress Biotech, Inc. (FBIO) Retained Earnings (Accumulated Deficit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Fortress Biotech, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2010 to 2024.
  • Fortress Biotech, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$710 M, a 8.31% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$710 M -$54.5 M -8.31% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$695 M -$60.6 M -9.56% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 -$686 M -$78.5 M -12.9% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$681 M -$96 M -16.4% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$656 M -$92.5 M -16.4% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$634 M -$86.8 M -15.8% Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$607 M -$91.2 M -17.7% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$585 M -$89.5 M -18.1% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 -$563 M -$71.6 M -14.6% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 -$547 M -$64.7 M -13.4% Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$516 M -$38.4 M -8.05% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 -$495 M -$33.2 M -7.19% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 -$492 M -$43 M -9.58% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 -$483 M -$46.5 M -10.7% Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$477 M -$56.7 M -13.5% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 -$462 M -$53.9 M -13.2% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 -$449 M -$53.7 M -13.6% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 -$436 M -$40 M -10.1% Dec 31, 2019 10-K/A 2021-04-09
Q3 2019 -$421 M -$49.3 M -13.3% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 -$408 M -$53.2 M -15% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 -$395 M -$61.7 M -18.5% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 -$396 M -$84.1 M -27% Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$371 M -$69.7 M -23.1% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 -$355 M -$80.2 M -29.2% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 -$333 M -$75.9 M -29.5% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 -$312 M -$66.9 M -27.3% Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$302 M -$73.9 M -32.4% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 -$275 M -$59.8 M -27.8% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 -$257 M -$54.9 M -27.1% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 -$245 M -$55.1 M -29% Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$228 M -$49.7 M -27.9% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 -$215 M -$54.9 M -34.3% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 -$202 M -$48.6 M -31.6% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 -$190 M -$48.4 M -34.2% Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$178 M -$40.1 M -29.1% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 -$160 M -$26.5 M -19.9% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 -$154 M -$25.1 M -19.5% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 -$142 M -$20.4 M -16.8% Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$138 M -$26.5 M -23.7% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 -$133 M -$29.7 M -28.6% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 -$129 M -$35.7 M -38.3% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 -$121 M -$37.2 M -44.1% Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$112 M -$36 M -47.7% Sep 30, 2013 10-Q 2013-11-01
Q2 2013 -$104 M -$34.1 M -49% Jun 30, 2013 10-Q 2013-08-05
Q1 2013 -$93 M -$29.9 M -47.4% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 -$84.2 M -$27.6 M -48.8% Dec 31, 2012 10-K 2014-03-14
Q3 2012 -$75.5 M -$25.7 M -51.5% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 -$69.6 M Jun 30, 2012 10-Q 2012-08-08
Q1 2012 -$63.1 M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 -$56.6 M -$36.4 M -180% Dec 31, 2011 10-K 2013-03-18
Q3 2011 -$49.9 M Sep 30, 2011 10-Q 2011-11-14
Q4 2010 -$20.2 M Dec 31, 2010 10-K 2012-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.